Skip to content

Group Visits for Patients with Enlarges Prostates: Enhancing Patient Care, Cutting Wait Times – Evidence from a Study Comparing Shared Appointments to One-on-One Sessions.

Improving Patient Care and Operational Efficiency with Shared Medical Appointment: Evidence from Randomized Control Trial in lower urinary tract symptoms secondary to benign prostatic hyperplasia - NILL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/01/061605
Enrollment
620
Registered
2024-01-18
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms

Interventions

Intervention1: Shared Medical Appointment: The patients who are allocated to the shared medical appointment group will be seen in groups of four by the doctor and post-appointment details and interact

Sponsors

Priyank Yadav
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: We will have the following inclusion criteria: 1. The patient must be 50 years or older. 2. The patient must have regular visits at Urology Clinic in SGPGIMS. 3. The patients should have come for follow up visits only, requiring no examination. 4. The patient should not have any symptoms requiring admission or any procedure with or without anaesthesia. 5. International Prostate Symptom Score (IPSS) of eight or more. 6. The patient should not require surgical intervention in the near future. 7. The patient must not wish to interact with a specific doctor.

Exclusion criteria

Exclusion criteria: We will have the following exclusion criteria: 1. Any physical or mental conditions in the patient or accompanying persons that preclude interaction in a group setting. 2. Participation of the patient in any other existing trial. 3. The patient had not indwelling catheters, urinary incontinence, anuria, gross haematuria, acute urinary retention, urinary tract infection, and prostate cancer. 4. Any patient who needs clinical examination will be excluded for reasons of privacy.

Design outcomes

Primary

MeasureTime frame
1. Patient waiting time 2. Patient consultation timeTimepoint: All primary outcomes will be measured at 0 and 6 months

Secondary

MeasureTime frame
1. Patient anxiety 2. Patient knowledge 3. Patient satisfaction 4. Engagement in SMA 5. Doctor’s productivity Timepoint: Secondary outcome will be measured at 0 and 6 months

Countries

India

Contacts

Public ContactPriyank Yadav

Sanjay Gandhi Postgraduate Institute of Medical Sciences

priyankmamc@gmail.com9013488138

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026